NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
NHS launches new polygenic scores trial for heart disease
29 Apr 2021
The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
NHS launches new polygenic scores trial for heart disease
29 Apr 2021
The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
NHS launches new polygenic scores trial for heart disease
29 Apr 2021
The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
NHS launches new polygenic scores trial for heart disease
29 Apr 2021
The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.